Novavax, Inc. (NVAX) reported a fourth-quarter 2023 loss of 1.44centspershare,muchwiderthantheZacksConsensusEstimateofalossof49cents.Intheyear−agoquarter,thecompanyreportedalossof2.28 per share.Revenues in the quarter amounted to 291.3million,alsomissingtheZacksConsensusEstimateof334.0 million. The top line declined 18.5% on a year-over-year basis.Quarter in DetailIn the reported quarter, the company recorded $251.4 million in product sales, reflecting a decrease of 1 ...